ECLANT Trademark

Trademark Overview


On Thursday, July 29, 2021, a trademark application was filed for ECLANT with the United States Patent and Trademark Office. The USPTO has given the ECLANT trademark a serial number of 79326760. The federal status of this trademark filing is REGISTERED as of Tuesday, October 11, 2022. This trademark is owned by Trio Medicines Limited. The ECLANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating digestive diseases; proprietary medicine that blocks gastrin receptors, for treatment of patients with hypergastriaemia; pharmaceutical preparations for the treatment of medical conditions associated with hypergastrinaemia
eclant

General Information


Serial Number79326760
Word MarkECLANT
Filing DateThursday, July 29, 2021
Status700 - REGISTERED
Status DateTuesday, October 11, 2022
Registration Number6868468
Registration DateTuesday, October 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating digestive diseases; proprietary medicine that blocks gastrin receptors, for treatment of patients with hypergastriaemia; pharmaceutical preparations for the treatment of medical conditions associated with hypergastrinaemia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTrio Medicines Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameTrio Medicines Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameTrio Medicines Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, February 27, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 2, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 1, 2023FINAL DISPOSITION PROCESSED
Wednesday, January 11, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 11, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 6, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 6, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022REFUSAL PROCESSED BY IB
Wednesday, June 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 18, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 7, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 7, 2022REFUSAL PROCESSED BY MPU
Tuesday, May 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 27, 2022ASSIGNED TO EXAMINER
Friday, December 3, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 25, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB